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including age, sex and time delays to admission. Interestingly, dyslipidemia and
history of MI was less frequent in PE group. Plasma CRP levels on admission
were markedly higher in PE patients. Prior chronic treatments were less frequent
in PE group, in particular for aspirin (11 vs 19%, p=0.027), ACE inhibitor (10 vs
18%, p=0.014) and statin (15 vs 23%, p=0.054). Acute treatments were similar,
except for BetaBlocker that were more used in patients without PE. Patients with
PE were more likely to suffer from STEMI and altered LVEF. Hospital complica-
tions such as death, or heart failure (12 vs 7%, p=0.016, 47 vs 28%, p=0.001), and
mechanical complications including atrial fibrillation, wall rupture, apical
thrombus and mitral regurgitation (respectively, 20 vs 9%, p<0.001, 7 vs 0.5%,
p<0.01, 8 vs 0.7%, p<0.01, and 8 vs 3%, p=0.03) were more frequent in PE group.
Conclusions: Our large study showed that, although PE is uncommon in
the contemporary era of acute MI, it is still associated with worse short term
prognosis, characterized by high rate of mechanical complications. Our works
also suggest a preventive effect of some CV drugs against the development of
PE following acute MI.
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Objectives: The aim of this study was to assess the prevalence and impact
on outcome of CIN occurring after primary PCI (pPCI) for STEMI, in addi-
tion to the information provided by the measure of renal function.
METHODS: In 924 consecutive STEMI patients undergoing pPCI, we mea-
sured serum creatinine concentration (CrC) and calculated creatinine clearance
(CrCl) at admission (in the cath-lab) and each day during hospitalization.
Renal impairment was defined as a CrCl <60ml/min. CIN was defined #1 –
by an increase of 25% of Cr C between the baseline and the peak (classic def-
inition) and, # 2 – by a decrease of 25% of CrCl according to the Cockroft-
Gault Formula (new definition). 
Results: Renal impairment was found in 26.1% at admission and in 29.6% of
patients after the pPCI and had a major impact on in-hospital mortality (13.8% vs.
2.25% in patients without renal dysfunction, OR 7.1; p<0.0001). The relation was
even stronger after pPCI (15.6% vs. 1.7%, OR 8.8; p<0.0001). Using definition#1,
CIN occurred in 17.2% (159) of patients and was associated with a three-fold
increase in mortality when compared with patients without CIN (11.6% vs. 3.9%,
OR 3.2, p=0.0036). The rate of CIN was 11.3% (104) with definition #2 and asso-
ciated with a four-fold increase in mortality (15.3% vs. 4.0%, OR 4.3, p=0.0005).
The combined effect on in-hospital mortality of baseline renal impairment and
CIN after pPCI is shown on figure 1.The mean volume of contrast media was sim-
ilar in patients developing CIN or not (218±44 vs. 217±50; p=0.8 definition #1;
213±39 vs. 218±49; p =0.5 definition #2) and did not relate to survival either
(219± 9 ml vs. 216± 2 ml; p=0.7).
Conclusions: In STEMI patients CIN is a major factor of in-hospital death
when it occurs in patients with basal renal impairment and seem independent
to the amount of contrast media. A new definition of CIN based on CrCl
seems more sensitive to predict mortality.
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Introduction: The present study was designed to identify the mid and long
term impact of limitations of daily activities (functional decline) on outcome
in a cohort of elderly ACS patients.
Methods: Clinical data including the Global Registry of Acute Coronary
Events (GRACE) score and assessment of functional status using Katz scale
was prospectively collected in a cohort of 272 patients 70 years old admitted
for an ACS. All cause mortality was assessed at 6-month and in alive patients
after the initial 6 months of follow-up.
Results: Mean age was 78+/-6 years (men 58%). Functional decline was
diagnosed in 28% of the cohort. At 6-month follow-up 38 patients died and
during a median follow up of 611 [1-1320] days after 6-month post ACS,
29 patients died. Functional decline was associated with both 6-month and
long-term outcome (HR=3.629 [1.914-6.881], p<0.0001 and HR=2.69 (1.28-
5.64), p=0.009 respectively). Functional decline remained associated with
both 6 months and long-term outcome in multivariate analysis. Functional
decline was systematically selected in the most predictive multivariate models
for the prediction of 6-month and long-term mortality in term of global model
fit, calibration and discrimination. While the multivariate model including the
GRACE score and functional decline had a good predictive value for the pre-
diction of 6-months mortality, the combination of functional decline to biolog-
ical data (low estimated Glomerular Filtration Rate and haemoglobin) had a
better predictive value for the prediction of long-term mortality than a model
combining functional decline to the GRACE score.
Conclusions: The present study provides strong evidence that functional
decline represents a short – and long-term prognosticator in elderly ACS
patients. Functional decline should be considered to achieve coordinated care
and thereby improve outcome in elderly.
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Background: Despite the superiority of primary angioplasty in the man-
agement of ST elevation myocardial infarction (STEMI), thrombolysis
remains more frequently used worldwide particularly in developing countries.
The aim of this analysis was to identify predictors of thrombolytic therapy
success in STEMI patients.
Methods: Among 1353 patients included in our MIRAMI (MonastIR
Acute Myocardial Infarction) registry between January 1995 and April 2011,
436 patients received thrombolysis. Streptokinase was the only lytic agent
used. Multivariate logistic regression was used to determine predictors of
thrombolysis success. 
Results: Thrombolysis success, defined as chest pain relief below 5 in a
scale from 1 to 10 and ST elevation resolution over 50% from baseline, was
obtained in 306 patients (70%). Time to treatment less than 3 hours (p=0.001;
OR= 2.13), smoking (p=0.001, OR=2.1), and inferior location (p=0.009,
OR=1.83) were identified as independent predictors of thrombolysis success.
Inversely, severe heart failure (Killip III and IV classes) were found to be pre-Mortality according to Renal Impairment and CIN
